Publication

Article

CURE

Winter Supplement 2010
Volume9
Issue 0

Details of Nipple Sparing

Things to know before deciding on a nipple-sparing mastectomy.

> There is still no consensus among doctors about nipple-sparing procedures.

> Nipple sparing is more accepted as prophylactic surgery for women at very high risk for developing breast cancer, or in cases where the tumor is small, away from the nipple and has other favorable features including negative nodes.

> The risk of recurrence and the long-term preservation of cosmetic results and sensation are not known.

> If you are interested in this option, be a good health consumer. Research your options and discuss them with your plastic surgeon and oncologist.

> An estimated 5 percent of women who get mastectomies choose the nipple-sparing option.

> Nipple-sparing mastectomy is typically covered by insurance, and it costs about the same as traditional reconstructive surgery.

> Online sources about nipple-sparing operations include Facing Our Risk of Cancer Empowered (www.facingourrisk.org), the American Cancer Society, (www.cancer.org) and The Breast Preservation Foundation (www.breastpreservationfoundation.org).

Related Videos
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Image of a woman with light shoulder-length hair, wearing rectangular glasses.
Image of man with grey hair.
Image of woman with blonde hair.